Worth an Arm and a Leg: The Critical Importance of Limb Ischemia

Javier A Valle^{1

2}, Stephen W Waldo^{1

2}

Affiliations

¹ 1 Division of Cardiology Department of Medicine University of Colorado Aurora CO.
² 2 Division of Cardiology Department of Medicine Veterans Affairs Eastern Colorado Health Care System Denver CO.

Editorial

Javier A Valle et al. J Am Heart Assoc. 2018.

. 2018 Aug 21;7(16):e010093.

doi: 10.1161/JAHA.118.010093.

Javier A Valle^{1

2}, Stephen W Waldo^{1

2}

¹ 1 Division of Cardiology Department of Medicine University of Colorado Aurora CO.
² 2 Division of Cardiology Department of Medicine Veterans Affairs Eastern Colorado Health Care System Denver CO.

No abstract available

Keywords: Editorials; peripheral artery disease; peripheral vascular disease; peripheral vasculature.

Comment on

Determinants of Long-Term Outcomes and Costs in the Management of Critical Limb Ischemia: A Population-Based Cohort Study.
Mustapha JA, Katzen BT, Neville RF, Lookstein RA, Zeller T, Miller LE, Jaff MR. Mustapha JA, et al. J Am Heart Assoc. 2018 Aug 21;7(16):e009724. doi: 10.1161/JAHA.118.009724. J Am Heart Assoc. 2018. PMID: 30369325 Free PMC article.

1. Nehler MR, Duval S, Diao L, Annex BH, Hiatt WR, Rogers K, Zakharyan A, Hirsch AT. Epidemiology of peripheral arterial disease and critical limb ischemia in an insured national population. J Vasc Surg. 2014;60:686–695.e2. - PubMed
1. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG. Inter‐society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg. 2007;45(suppl S):S5–S67. - PubMed
1. Sigvant B, Kragsterman B, Falkenberg M, Hasvold P, Johansson S, Thuresson M, Nordanstig J. Contemporary cardiovascular risk and secondary preventive drug treatment patterns in peripheral artery disease patients undergoing revascularization. J Vasc Surg. 2016;64:1009–1017.e3. - PubMed
1. Hunink MG, Wong JB, Donaldson MC, Meyerovitz MF, de Vries J, Harrington DP. Revascularization for femoropopliteal disease: a decision and cost‐effectiveness analysis. JAMA. 1995;274:165–171. - PubMed
1. Stoner MC, Defreitas DJ, Manwaring MM, Carter JJ, Parker FM, Powell CS. Cost per day of patency: understanding the impact of patency and reintervention in a sustainable model of healthcare. J Vasc Surg. 2008;48:1489–1496. - PubMed